Cargando…
Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
Autores principales: | Ohmura, Shunya, Marchetto, Aruna, Orth, Martin F., Li, Jing, Jabar, Susanne, Ranft, Andreas, Vinca, Endrit, Ceranski, Katharina, Carreño-Gonzalez, Martha J., Romero-Pérez, Laura, Wehweck, Fabienne S., Musa, Julian, Bestvater, Felix, Knott, Maximilian M. L., Hölting, Tilman L. B., Hartmann, Wolfgang, Dirksen, Uta, Kirchner, Thomas, Cidre-Aranaz, Florencia, Grünewald, Thomas G. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314608/ https://www.ncbi.nlm.nih.gov/pubmed/34315482 http://dx.doi.org/10.1186/s12943-021-01393-9 |
Ejemplares similares
-
Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma
por: Dallmayer, Marlene, et al.
Publicado: (2019) -
Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients
por: Sannino, Giuseppina, et al.
Publicado: (2019) -
Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma
por: Cidre-Aranaz, Florencia, et al.
Publicado: (2022) -
Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies
por: Knott, Maximilian M. L., et al.
Publicado: (2020) -
Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
por: Marchetto, Aruna, et al.
Publicado: (2020)